Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Citi
Argus Health
Deloitte
Boehringer Ingelheim
Cantor Fitzgerald
Harvard Business School
McKinsey

Generated: February 16, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076175

« Back to Dashboard

NDA 076175 describes MEFLOQUINE HYDROCHLORIDE, which is a drug marketed by Barr, Hikma Intl Pharms, Sandoz, Us Army Walter Reed, and West-ward Pharms Int, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the MEFLOQUINE HYDROCHLORIDE profile page.

The generic ingredient in MEFLOQUINE HYDROCHLORIDE is mefloquine hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.
Summary for 076175
Tradename:MEFLOQUINE HYDROCHLORIDE
Applicant:Sandoz
Ingredient:mefloquine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076175

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Feb 20, 2002TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Cantor Fitzgerald
Express Scripts
AstraZeneca
Teva
Farmers Insurance
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.